Happy new year from Movement Disorders Foundation

As we begin a new year, the board and staff of Movement Disorders Foundation would like to thank the many researchers, physicians and volunteer advocates for their tireless efforts in making a difference in the lives of people living with movement disorders.

We would like to give thanks, as well, to our dedicated community of supporters who came together to rally for movement disorders research and education on Colorado Gives Day. As promised, every gift made during that campaign was doubled through the generous support of our board of directors!

Best of all, Movement Disorders Foundation will continue to match contributions received in the new year - dollar for dollar - in our commitment to support the most promising translational research and treatments in movement disorders. We need your support to ensure we can continue finding, assessing and supporting today's most innovative "undiscovered pioneers."

Please support our efforts with your tax-deductible contribution during this special match. Click here and double your impact for MDF research and education. The first $5,000 in contributions we receive through March 31, 2023, will be matched one-to-one.

Working together to outsmart Huntington's disease

The Perspective Program is evaluating the safety and efficacy of an investigational oral drug in adults with early Huntington’s disease. This investigational drug is believed to specifically target cognitive symptoms. The program is comprised of several clinical research studies. Click here to learn more.

Note: Investigational drugs are not approved by a health authority for any use, as the safety and efficacy have not been established.

Parkinson’s breakthrough: scientists have identified a key molecule

Adenosine, a neurotransmitter, has been found to act as a brake on dopamine, another neurotransmitter involved in motor control, by researchers at Oregon Health & Science University.

The discovery has the potential to immediately suggest new avenues for drug development to treat the symptoms of Parkinson’s disease. Click here to learn more.

Research opportunity for HD patients and caregivers

Rare Patient Voice (RPV) is recruiting patients and caregivers living in United States for an important Huntington's disease study. This is a 30-minute online survey, and the compensation is $50. Please sign up here to receive an email invitation to a screening survey to see if you qualify.

Rare Patient Voice connects patients and caregivers with the opportunity to voice their opinions through surveys and interviews to improve medical products and services, while earning cash rewards.